Navigation Links
MedImmune to Present Nine Abstracts Related to Influenza Vaccination at First Online National Immunization Conference
Date:3/26/2012

GAITHERSBURG, Md., March 26, 2012 /PRNewswire/ -- MedImmune announced today it will present nine abstracts at the National Immunization Conference Online (NIC Online), from March 26 – 28, 2012.  This is the first virtual conference, where presenters and attendees will participate in live or archived sessions entirely online. 

MedImmune is presenting new research on pediatric influenza vaccination and the safety and efficacy of live attenuated influenza vaccine. This research reinforces MedImmune's commitment to influenza prevention. With the conference being held online for the first time, MedImmune will share its findings through a widely accessible format to a broader medical audience.

"We believe the data being presented at NIC Online will help enhance the medical community's understanding of influenza vaccine safety and efficacy and help identify ways to potentially increase U.S. influenza vaccination rates," said Chris Ambrose, M.D., MedImmune's Senior Director of Medical & Scientific Affairs. 

For more information on this virtual conference and how to get access, visit the NIC web site: http://www.cdc.gov/vaccines/events/nic/default.htm. The conference agenda is available at http://cdc.confex.com/cdc/nic2012/webprogram/meeting.html.

MedImmune abstracts to be presented at NIC Online include:

  • A Post-licensure Evaluation of the Safety of Live Attenuated Influenza Vaccine (LAIV) in Children 2 to 4 Years of Age. Baxter R, et al. March 26, 2012. Online Poster Presentation
  • A Post-licensure Evaluation of the Safety of Live Attenuated Influenza Vaccine (LAIV) in U.S. Children 5 to 17 Years of Age. Baxter R, et al. March 26, 2012. Online Poster Presentation   
  • Does Live Attenuated Influenza Vaccine (LAIV) Reduce All-Cause Acute Otitis Media in Children? Heikkenin T, et al. March 26, 2012. Online Poster Presentation
  • Do Influenza Illness Symptoms Differ Among Vaccinated and Unvaccinated Children? Ambrose CS, et al. March 26, 2012. Online Poster Presentation
  • Improved Timing of Availability and Administration of Influenza Vaccine Through the Vaccines for Children Program From 2007 to 2011. Ambrose CS, et al. March 26, 2012. Online Poster Presentation
  • Interoffice Variability in the Delivery of Influenza Vaccine by US Pediatric Offices. Toback SL, et al. March 26, 2012. Online Poster Presentation
  • Meta-Analysis of the Efficacy of Live Attenuated Influenza Vaccine (LAIV) in Children 2 Through 17 Years of Age. Ambrose CS, et al. March 26, 2012. Online Poster Presentation  
  • Pediatric Influenza Vaccination by Office-Based Pediatricians and Family Physicians During the 2010–2011 Influenza Season. Toback SL, et al. March 26, 2012. Online Poster Presentation
  • Smaller Pediatric Offices Have Higher In-Office Influenza Vaccination Rates. Toback SL, et al. March 26, 2012. Online Poster Presentation

About MedImmune

MedImmune, the global biologics arm for AstraZeneca PLC, has approximately 3,500 employees worldwide and is headquartered in Gaithersburg, Maryland. For more information, visit MedImmune's website at http://www.medimmune.com/


'/>"/>
SOURCE MedImmune
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. MedImmune Announces FDA Approval of First Four-strain Flu Vaccine, FluMist® Quadrivalent (Influenza Vaccine Live, Intranasal)
2. AgonOx Partners with MedImmune for Development of OX40 Agonists in Cancer Therapy
3. MedImmune To Present Eight Abstracts on Projects Regarding Thoracic and Respiratory Issues at the Annual American Thoracic Society International Conference
4. Pfenex Announces Strategic Collaboration With MedImmune for the Use of Pfenex Expression Technology™
5. MedImmune to Present 11 Abstracts on Influenza at 45th Annual National Immunization Conference
6. MedImmune In-Licenses Clinical-Stage Anti-Inflammatory Monoclonal Antibody From Amgen
7. MedImmune Announces Winners of the 5th Annual Respiratory, Inflammation and Autoimmunity Research Abstract Competition
8. MedImmune Focused on Revolutionizing Cancer Care
9. MedImmune to Present Five Abstracts on RSV at Pediatric Academic Societies Annual Meeting
10. MedImmune to Present Data on RSV and Influenza at 2009 American Academy of Pediatrics National Conference & Exhibition
11. MedImmune Funds Study to Help Gain Insights Into Full Burden of RSV Disease Among Premature Infants
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/23/2016)... 2016 Gamida Cell, a leader ... cancer and orphan genetic diseases, announced today it has ... from the Israel Innovation Authority (formerly the Office of ... and Industry. The mission of the Israel Innovation Authority ... including science and technology, while stimulating economic growth. ...
(Date:5/20/2016)... -- The Biotech arena remains under immense ... is not far from recovering. There are great companies ... four equities: Anacor Pharmaceuticals Inc. (NASDAQ: ANAC ... Pharmaceuticals Inc. (NASDAQ: ARLZ ), and Infinity ... for your free trading alerts on these biotech stocks ...
(Date:5/19/2016)... , May 19,2016 ... at Digestive Disease Week Meeting and 91 st ... Mauna Kea Technologies (Euronext: MKEA, OTCQX: ... endomicroscopy platform, today announced that its Cellvizio platform ... focused on gastroenterology during the month of May. ...
Breaking Medicine Technology:
(Date:5/24/2016)... ... May 24, 2016 , ... Regenerative Medicine is being transformed ... stem cell therapy technology, protocols and patient results as have been achieved with ... a more accessible standard of care for patients worldwide. , As the Medical Advisory ...
(Date:5/24/2016)... ... May 24, 2016 , ... Backed by decades of ... each job, ensuring the best suited solution to meet regulatory requirements. Their professional ... their lab in Istanbul. , Metroloji Okulu specializes in MadgeTech’s line of medical ...
(Date:5/24/2016)... ... May 24, 2016 , ... American Gene Technologies International, ... to its board of directors. Otterstatter is co-founder, president and CEO of ... innovations that lead to broad-based healthcare solutions. , “Jon knows how to create ...
(Date:5/24/2016)... ... 2016 , ... WaterAid launched the #perioddrama campaign to mark Menstrual Hygiene Day on ... around the world who do not have access to a toilet, even when they’re on ... dread of #perioddrama. The (sometimes hilarious) results help shine a light on the awkwardness that ...
(Date:5/24/2016)... ... May 24, 2016 , ... Aloria Health ... To Begin In June , Aloria Health, specializing in a re-imagined, client-oriented approach ... Aloria Milwaukee, its first treatment facility for outpatient, day treatment and residential care. ...
Breaking Medicine News(10 mins):